Edition:
United Kingdom

Pulmatrix Inc (PULM.OQ)

PULM.OQ on NASDAQ Stock Exchange Global Market

0.34USD
16 Aug 2018
Change (% chg)

$-0.02 (-5.16%)
Prev Close
$0.36
Open
$0.36
Day's High
$0.36
Day's Low
$0.33
Volume
84,760
Avg. Vol
230,918
52-wk High
$2.67
52-wk Low
$0.28

Chart for

About

Pulmatrix, Inc. is a clinical stage biopharmaceutical company developing inhaled therapies to address serious pulmonary disease. The Company’s product pipeline is focused on advancing treatments for rare diseases, including PUR1900, an inhaled anti-fungal for patients with lung disease, including cystic fibrosis. In addition,... (more)

Overall

Beta: 2.02
Market Cap(Mil.): $43.07
Shares Outstanding(Mil.): 20.12
Dividend: --
Yield (%): --

Financials

  PULM.OQ Industry Sector
P/E (TTM): -- 85.68 32.76
EPS (TTM): -1.37 -- --
ROI: -104.24 1.78 14.61
ROE: -122.80 3.28 16.33

BRIEF-Pulmatrix Reports 2017 Financial Results; Provides 2018 Outlook On Pulmonary Disease Pipeline

* PULMATRIX REPORTS 2017 FINANCIAL RESULTS; PROVIDES 2018 OUTLOOK ON PULMONARY DISEASE PIPELINE

13 Mar 2018

Earnings vs. Estimates